Headquartered in Basel, Switzerland, the Straumann Group (SIX: STMN) is a global leader in implant and restorative dentistry and oral tissue regeneration. Collaborating with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants and instruments, CADCAM prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss.
The business model illustrates how Straumann’s businesses and activities are interwoven and interconnected. More about the company structure, organization and management can be found in the chapter on Corporate Governance.
Originally founded in 1954 as a research institute specializing in alloys, Straumann moved into the field of osteosynthesis implants in the 1970s and then focused exclusively on dental implants in 1990.